REGENXBIO Inc.(RGNX)
Biotechnology
Gene Therapy & Gene Editing
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | PAKOLA STEVE Chief Medical Officer | Sale | -15,309 | -6.17%232,617 | $11.02 | $168,705 | View SEC filing | |
| 2026-03-12 | PAKOLA STEVE Chief Medical Officer | Sale | -5,124 | -2.02%247,926 | $10.35 | $53,033 | View SEC filing | |
| 2025-10-10 | Simpson Curran Chief Executive Officer | Sale | -20,811 | -8.78%216,162 | $12.62 | $262,635 | View SEC filing | |
| 2025-10-01 | Simpson Curran Chief Executive Officer | Sale | -7,624 | -3.12%236,973 | $10.03 | $76,469 | View SEC filing | |
| 2025-09-12 | Simpson Curran Chief Executive Officer | Sale | -7,734 | -3.07%244,597 | $10.02 | $77,495 | View SEC filing | |
| 2025-05-14 | Mills Kenneth T. Director | Sale | -20,602 | -4.16%475,103 | $7.91 | $163,046 | View SEC filing | |
| 2024-10-02 | KARABELAS ARGERIS N Director | Sale | -10,000 | -46.98%11,286 | $10.11 | $101,052 | View SEC filing | |
| 2024-09-04 | KARABELAS ARGERIS N Director | Sale | -10,000 | -46.98%11,286 | $11.56 | $115,588 | View SEC filing | |
| 2024-08-05 | KARABELAS ARGERIS N Director | Sale | -10,100 | -47.23%11,286 | $13.51 | $136,454 | View SEC filing | |
| 2024-08-05 | Simpson Curran Chief Executive Officer | Sale | -100 | -0.06%170,037 | $15.00 | $1,500 | View SEC filing | |
| 2024-07-30 | KARABELAS ARGERIS N Director | Sale | -11,000 | -49.36%11,286 | $15.04 | $165,495 | View SEC filing | |
| 2024-07-30 | Simpson Curran Chief Executive Officer | Sale | -9,648 | -5.37%170,137 | $15.04 | $145,106 | View SEC filing | |
| 2024-07-26 | Mills Kenneth T. Director | Sale | -27,590 | -2.91%408,035 | $13.88 | $382,934 | View SEC filing | |
| 2024-07-18 | Mills Kenneth T. Director | Sale | -2,410 | -0.05%408,035 | $13.77 | $33,192 | View SEC filing | |
| 2024-07-03 | KARABELAS ARGERIS N Director | Sale | -10,000 | -46.98%11,286 | $11.27 | $112,691 | View SEC filing | |
| 2024-05-16 | Mills Kenneth T. President and CEO | Sale | -15,000 | -3.55%408,035 | $15.81 | $237,222 | View SEC filing | |
| 2024-04-17 | Mills Kenneth T. President and CEO | Sale | -15,000 | -3.55%408,035 | $18.19 | $272,871 | View SEC filing | |
| 2024-03-18 | Mills Kenneth T. President and CEO | Sale | -15,000 | -3.55%408,035 | $21.86 | $327,942 | View SEC filing | |
| 2024-03-07 | PAKOLA STEVE Chief Medical Officer | Sale | -12,878 | -10.73%107,192 | $28.36 | $365,220 | View SEC filing | |
| 2024-02-16 | Mills Kenneth T. President and CEO | Sale | -15,000 | -3.55%408,035 | $16.76 | $251,349 | View SEC filing | |
| 2024-01-18 | Mills Kenneth T. President and CEO | Sale | -45,000 | -9.93%408,035 | $15.18 | $682,992 | View SEC filing | |
| 2024-01-04 | PAKOLA STEVE Chief Medical Officer | Sale | -17,237 | -13.85%107,192 | $17.39 | $299,789 | View SEC filing | |
| 2023-12-21 | Mills Kenneth T. President and CEO | Sale | -45,000 | -11.24%355,289 | $19.68 | $885,825 | View SEC filing | |
| 2023-01-05 | PAKOLA STEVE Chief Medical Officer | Sale | -3,138 | -20.49%12,175 | $22.17 | $69,559 | View SEC filing | |
| 2022-08-31 | Vasista Vittal Chief Financial Officer | Sale | -2,400 | -1.74%135,160 | $30.24 | $72,573 | View SEC filing |
1-25 of 188